15 citations
,
March 2023 in “BioMed” This review discusses multisystem inflammatory syndrome in adults (MIS-A) related to SARS-CoV2 and outlines the existing knowledge and unanswered questions, reporting no new clinical results.
June 2026 in “Journal of Investigative Dermatology” This study reported that the anti-γc antibody hC2 restored hair follicle homeostasis and suppressed hair loss in an AA-like mouse model by inhibiting autoreactive T-cell activity, suggesting that hC2 may offer a safer and more effective treatment for alopecia areata compared to current Jak inhibitors.
January 2026 in “Medico Research Chronicles” This study reports a case where a young male experienced improved hair condition following individualized homeopathic treatment and integrative therapy after hair thinning post-COVID-19 infection, suggesting potential benefits of non-invasive approaches at Dr Batra’s.
December 2024 in “PubMed” This case study describes a 55-year-old Japanese male with Vogt-Koyanagi-Harada disease who experienced no hair regrowth but did have hair repigmentation after localized steroid injections, highlighting an unusual late-onset poliosis and alopecia, which has not been previously reported.
17 citations
,
December 1951 in “Experimental biology and medicine” In this study of immature male albino rats on a vitamin B12-deficient diet, vitamin B12 supplementation improved body, hair, and thymus growth more effectively than aureomycin when countering the negative effects of cortisone.
January 2023 in “Acta dermatovenerologica Alpina, Pannonica et Adriatica (Tiskana izd.)” This review details skin conditions in children and adolescents related to the SARS-CoV-2 pandemic, emphasizing mask-related acne and various cutaneous manifestations linked to infection and vaccination, with most being mild or nonspecific.
July 2021 in “Veterinary record/The veterinary record” This report from SRUC VS highlighted a suspected case of Schmallenberg virus infection in a calf born to an imported heifer, noting consistent clinical signs and seroconversion in the dam.
June 2024 in “Journal of Clinical Oncology” This study observed that dalpiciclib is associated with fewer adverse events like diarrhea and hepatotoxicity compared to other CDK4/6 inhibitors, potentially offering better patient-perceived safety and quality of life.
48 citations
,
August 2022 in “Chemical Biology & Drug Design” This review outlines computational strategies, including chemogenomics and drug repositioning, for coronavirus drug discovery and reports no new clinical findings; the authors highlight the advantages of these methods in rapidly identifying therapeutic candidates.
August 2024 in “Indian Journal of Animal Research” In this study, dermatophytosis in cattle around Parbhani was found to have a prevalence of 17.2%, with Clove oil treatment showing the quickest recovery in 7 days.
3 citations
,
May 2024 in “Indian Journal of Dermatology” In this case report, researchers identified a potential adverse skin reaction, called SDRIFE or Baboon syndrome, caused by the drug tofacitinib in a 19-year-old woman being treated for alopecia subtotalis, leading the authors to recommend discontinuation of the drug.
1 citations
,
July 2024 in “Journal of Investigative Dermatology” VYN201 shows promise as a safe and effective treatment for non-segmental vitiligo.
February 2012 in “Hospital Pharmacy” This article discusses the importance of raising awareness about specific adverse drug reactions, methods of prevention, and the significance of reporting them to the FDA's MedWatch program, but reports no new clinical results.
3 citations
,
March 2022 in “Journal of Infection” This study observed that SARS-CoV-2 shedding significantly decreased after remdesivir treatment, irrespective of RT-PCR cycle threshold values, suggesting early de-isolation might be possible in severe COVID-19 cases.
April 2011 in “Reactions Weekly” May 2022 in “Gastroenterology” This study suggests that supplemental testosterone therapy in men with hepatitis C virus may be associated with a modest reduction in hepatocellular carcinoma risk, challenging concerns about its potential to increase cancer risk.
5 citations
,
April 2020 in “Journal of The American Academy of Dermatology” In this study, among patients taking hydroxychloroquine for dermatologic or rheumatologic conditions, none developed symptoms suggestive of SARS-CoV-2 infection despite Italy's high infection rate at the time.
9 citations
,
April 2024 in “Cureus” This study outlines the features and diagnosis of Vogt-Koyanagi-Harada disease, highlighting its association with specific genes, its prevalence among pigmented races, and treatment with systemic steroids and immunosuppressants.
4 citations
,
April 2007 in “Journal of Pediatric Gastroenterology and Nutrition” This case report describes a 16-year-old liver transplant patient with previous chicken pox infection experiencing disseminated varicella zoster virus infection with pneumonia, highlighting the importance of early acyclovir treatment in immunocompromised patients.
14 citations
,
June 2023 in “Journal of Infection and Public Health” This study observed a low rate of long-COVID lasting more than three months among mostly vaccinated healthcare workers during the Omicron wave, suggesting that further research is needed to assess the impact of different vaccines on long-COVID-19 in this group.
1 citations
,
October 2025 in “Journal of the American Society of Nephrology” In this case report, a 56-year-old man developed acute granulomatous interstitial nephritis following Moderna Covid-19 vaccination, with his kidney function improving after steroid treatment but declining upon cessation; the report suggests a vaccine-related cause given his atypical clinical course.
The study reported that vismodegib showed significant effectiveness in treating basal cell carcinoma, particularly in patients with Gorlin-Goltz syndrome or locally advanced BCC, but also highlighted substantial side effects, requiring careful management to prevent treatment resistance and maintain remission.
11 citations
,
December 2020 in “Clinics in Dermatology” This review discusses the impact of COVID-19 on dermatology practice in Iran, emphasizing adaptation to challenges such as teledermatology and new cutaneous COVID-19 symptoms, but reports no new clinical results.
2 citations
,
November 2025 in “Pharmacology Research & Perspectives” This study analyzed post-marketing data from the U.S. FDA Adverse Event Reporting System and identified both known and new safety concerns for Avacopan, an anti-neutrophil cytoplasmic antibodies-associated vasculitis treatment, emphasizing the need for monitoring during early treatment stages.
7 citations
,
December 2022 in “Skin Appendage Disorders” This study found that among anti-TNF-α agents, certolizumab is the least likely to cause paradoxical reactions such as psoriatic alopecia and appears to be an effective and safe option for managing psoriasis and PsA while minimizing these risks.
1 citations
,
January 2022 in “South Florida Journal of Development” This report describes a case of cryptococcal meningitis in an immunosuppressed patient in Manaus, highlighting the need for improved health education on preventing cryptococcosis.
December 2013 in “Journal of Pharmaceutical and Scientific Innovation” This study found that the Ayurvedic formulation Trichup Capsule significantly increased hair length and diameter in treated animals without signs of toxicity or mortality.
1 citations
,
September 2023 in “Journal of the American Academy of Dermatology” COVID-19 vaccines have been linked to an increase in hair loss conditions.
March 2021 in “Arrow - TU Dublin (Technological University Dublin)” This study tested a folate-conjugate drug delivery system and found its cytotoxicity depends on whether the treated cells overexpress folate receptors, suggesting potential for targeted chemotherapy.
4 citations
,
July 2024 in “Indian Dermatology Online Journal” This study developed and finalized standard treatment workflows for thirteen common skin diseases, such as acne, eczema, and psoriasis, to optimize management across primary, secondary, and tertiary care centers in the country, with resources available both online and in physical formats.